$36.68 3.8%
Price vs. AI Score (Last 150 days)
Data gathered: December 1

Data Bits

Data Bits Value / Change Benchmark
Job Posts 95 -1%
Sentiment 63 -6%
Webpage traffic 42,000 38.7%
Employee Rating 88 0%
Google Adspend $1,426 16.2%
Google Trends -100%
Linkedin Employees 1,092 N/A
Patents 146 1.4%
4chan Mentions 0%
Facebook Engagement 93 -5.1%
Facebook followers 1,200 0%
Stocktwits Mentions 1 0%
Stocktwits Subscribers 325 0.3%
Twitter Followers 2,333 0.1%
Youtube Subscribers 870 0.2%
Instagram Followers 625 0.2%
News Mentions 0%
Reddit Mentions 0%
Business outlook 80 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Atricure

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally.

Price $36.68
Target Price Sign up
Market Cap $1.68B
Dividend Yield 0.0621
Industry Medical & Dental Instruments

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '2398M24M74M-9.1M-5.3M
Q2 '23101M24M77M-5.1M-1.8M
Q1 '2393M24M70M-6.5M-3.8M
Q4 '2288M23M65M-4.2M-1.5M
Q3 '2283M22M62M-12M-9.7M

Insider Transactions

Dahlquist Karl S. filed to sell 30,789 shares at $34.4.
November 3 '23
Dahlquist Karl S. filed to sell 32,037 shares at $57.1.
July 28 '23
Prange Karen filed to sell 16,140 shares at $47.9.
June 12 '23
Dahlquist Karl S. filed to sell 34,897 shares at $47.
June 7 '23
Yuen Maggie filed to sell 4,682 shares at $47.
May 30 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.